|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 235/12 | |
| A61K 31/4184 | |||
| A61P 35/00 |
| (11) | Number of the document | 2861564 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13729324.7 |
| Date of filing the European patent application | 2013-06-14 | |
| (97) | Date of publication of the European application | 2015-04-22 |
| (45) | Date of publication and mention of the grant of the patent | 2018-08-08 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2013/062347 |
| Date | 2013-06-14 |
| (87) | Number | WO 2013/189847 |
| Date | 2013-12-27 |
| (30) | Number | Date | Country code |
| 201261661374 P | 2012-06-19 | US | |
| 201261670158 P | 2012-07-11 | US |
| (72) |
LUBBE, Mathias, DE
HOFMEIER, Harald, DE
SCHICKANEDER, Helmut, DE
SCHICKANEDER, Christian, DE
BUSCHAUER, Armin, DE
BERNHARDT, Günther,, DE
HUBER, Stefan, DE
LIMMERT, Michael, DE
|
| (73) |
Synbias Pharma AG,
Pestalozzistrasse 2, 8200 Schaffhausen,
CH
|
| (54) | BENDAMUSTINE DERIVATIVES AND RELATED COMPOUNDS, AND MEDICAL USE THEREOF FOR CANCER THERAPY |
| BENDAMUSTINE DERIVATIVES AND RELATED COMPOUNDS, AND MEDICAL USE THEREOF FOR CANCER THERAPY |